Mammalian Toxicology and Pathology Our familiarity with regulatory guidelines and long experience with a variety of therapeutic agents and industrial chemicals makes us the logical choice for your toxicology needs. 94025 SRI's Mammalian Toxicology and Pathology Testing Program is an integral part of the safety evaluation services that SRI provides to clients. Our capabilities in mammalian toxicology include studies in mice, rats, and hamsters and studies in nonrodents such as rabbits, beagles, and minipigs.
Clients can choose from a wide spectrum of administration routes.
Working with the client, we design the required protocols and ensure that regulatory guidelines from around the world are followed. We perform the full spectrum of acute, subchronic, chronic, and carcinogenicity studies typically required for new pharmaceuticals and biotechnology products. In addition, we can test biomedical engineering products and medical devices in a variety of protocols. We have experience with a wide range of therapeutic agents, such as anticancer drugs, anti-HIV compounds, vaccines, antisense therapeutics, nucleosides, peptides, proteins, and growth factors. We can also conduct toxicity studies with industrial chemicals.